Evaxion A (EVAX) Total Non-Current Liabilities (2021 - 2025)

Evaxion A (EVAX) reported Total Non-Current Liabilities of $7.1 million for Q4 2025, down 27.2% on a YoY basis from $9.8 million in Q4 2024, and down 34.76% quarter-over-quarter from $10.9 million in Q2 2025.

Evaxion A (EVAX) Total Non-Current Liabilities (2021 - 2025) Analysis & Trends

Evaxion A has reported Total Non-Current Liabilities for 5 years, with the latest figure at $7.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 27.2% year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2025 stood at $7.1 million (down 27.2% YoY), and the FY2025 full-year result was $7.1 million, down 27.2% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $7.1 million, down from $10.9 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $10.9 million in Q2 2025, with the low at $1.0 million in Q2 2021.
  • Historically, Total Non-Current Liabilities has averaged $7.5 million across 5 years, with a median of $9.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 819.77% — and 2025, when it declined 27.2%.
  • Evaxion A's Total Non-Current Liabilities stood at $3.4 million in 2021, then jumped by 192.68% to $10.0 million in 2022, then increased by 5.76% to $10.5 million in 2023, then slipped by 7.26% to $9.8 million in 2024, then retreated by 27.2% to $7.1 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $7.1 million (Q4 2025), $10.9 million (Q2 2025), and $9.8 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 7.32 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 7.11 Mn
Jun 30, 2025 10.90 Mn
Dec 31, 2024 9.77 Mn
Jun 30, 2024 10.16 Mn
Dec 31, 2023 10.53 Mn
Jun 30, 2023 10.17 Mn
Dec 31, 2022 9.96 Mn
Jun 30, 2022 9.45 Mn
Mar 31, 2022 10.01 Mn
Dec 31, 2021 3.40 Mn
Sep 30, 2021 3.54 Mn
Jun 30, 2021 1.03 Mn
Mar 31, 2021 1.11 Mn